Company: JUNS
Filing Date: 2025-03-28
Form Type: 10-K
Source: 0001641172-25-001261
Chunk: 1788

Company: JUPITER NEUROSCIENCES, INC.
Filing Date: 2025-03-28
Form: 10-K
Item: Item 8
Chunk 1788
---
“Accounting Restatement” (as defined in the Clawback Policy), we shall, subject to certain limited exceptions as
described in the Clawback Policy, recover certain incentive-based compensation from executive officers who are or have been
designated as an “officer” by the Board of Directors in accordance with Exchange Act Rule 16a-1(f). Compensation that
shall be recovered under the Clawback Policy generally includes “Incentive-Based Compensation” (as defined in the
Clawback Policy) received during the three-year period prior to the “Accounting Restatement Determination Date” (as
defined in the Clawback Policy) that exceeds the amount that otherwise would have been received by the “officer” had
such compensation been determined based on the restated amounts in the financial restatement. Under the Clawback Policy,
“Incentive-Based Compensation” includes any compensation that is granted, earned, or vested based, in whole or in part,
upon the attainment of a Financial Reporting Measure (as defined in the Clawback Policy).

Policy
Prohibiting Insider Trading and Related Procedures.

The
Company adopted an insider trading policy governing the purchase, sale, and other dispositions of the Company’s securities by directors,
senior management, and employees. A copy of the insider trading policy is filed as an exhibit to this Annual Report on Form 10-K.

Communications
with the Board

Stockholders
and other interested parties can send communications to one or more members of the Board by writing to the Board or specific directors
or group of directors at the following address: Jupiter Neurosciences, Inc. Board of Directors, c/o Corporate Secretary, 1001 North US
Hwy 1, Suite 504, Jupiter, FL 33477. Any communication will be promptly distributed by our Corporate Secretary to the individual director
or directors named in the communication or to all directors if addressed to the entire Board.

102

Limitation
on Liability and Indemnification of Officers and Directors

Our
certificate of incorporation provides that our officers and directors will be indemnified by us to the fullest extent authorized by Delaware
law, as it now exists or may in the future be amended. In addition, our certificate of incorporation provides that our directors will
not be personally liable for monetary damages to us for breaches of their fiduciary duty as directors, except to the extent such exemption
from liability or limitation thereof is not permitted by the Delaware General Corporation Law (“DGCL”).

Our
certificate of